GR1000918B - Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών. - Google Patents

Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.

Info

Publication number
GR1000918B
GR1000918B GR900100796A GR900100796A GR1000918B GR 1000918 B GR1000918 B GR 1000918B GR 900100796 A GR900100796 A GR 900100796A GR 900100796 A GR900100796 A GR 900100796A GR 1000918 B GR1000918 B GR 1000918B
Authority
GR
Greece
Prior art keywords
active substance
acids containing
preparing compounds
containing sulphur
carbonic acids
Prior art date
Application number
GR900100796A
Other languages
Greek (el)
English (en)
Other versions
GR900100796A (en
Inventor
Andreas Dr Baur
Bernhard Dr Prof Fleckenstein
Thomas Dr Harrer
Joachim Dr Prof Kalden
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of GR900100796A publication Critical patent/GR900100796A/el
Publication of GR1000918B publication Critical patent/GR1000918B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR900100796A 1989-11-09 1990-11-08 Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών. GR1000918B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE4015728 1990-05-16

Publications (2)

Publication Number Publication Date
GR900100796A GR900100796A (en) 1992-04-17
GR1000918B true GR1000918B (el) 1993-03-16

Family

ID=25886910

Family Applications (3)

Application Number Title Priority Date Filing Date
GR920100378A GR1001503B (el) 1989-11-09 1990-11-08 Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
GR900100796A GR1000918B (el) 1989-11-09 1990-11-08 Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.
GR950402804T GR3017695T3 (en) 1989-11-09 1995-10-11 Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR920100378A GR1001503B (el) 1989-11-09 1990-11-08 Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR950402804T GR3017695T3 (en) 1989-11-09 1995-10-11 Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses.

Country Status (19)

Country Link
US (1) US5334612A ( )
EP (1) EP0427246B1 ( )
JP (1) JPH03188021A ( )
AT (2) ATE126053T1 ( )
BE (2) BE1003834A5 ( )
CA (1) CA2029599C ( )
CH (1) CH684054A5 ( )
DE (3) DE9017987U1 ( )
DK (3) DK0427246T3 ( )
ES (2) ES2076279T3 ( )
FR (1) FR2653997B1 ( )
GB (1) GB2239797B ( )
GR (3) GR1001503B ( )
IE (1) IE67874B1 ( )
IT (1) IT1246328B ( )
LU (1) LU87834A1 ( )
NL (1) NL9002438A ( )
PT (1) PT95827B ( )
SE (1) SE508601C2 ( )

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE162715T1 (de) * 1991-07-05 1998-02-15 Asta Medica Ag Verwendung von schwefel enthaltenden carbonsäuren zur bekämpfung von pathophysiologisch bedingten erregungsstörungen
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
DE9321574U1 (de) * 1992-03-11 2000-06-29 Asta Medica Ag Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 (de) * 1992-10-15 1992-12-03 Asta Medica AG, 6000 Frankfurt Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure
EP0690709A1 (en) * 1993-03-26 1996-01-10 DINU, Constantin Romulus Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
AU737038B2 (en) * 1996-07-05 2001-08-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998023606A1 (fr) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6900338B1 (en) * 1998-11-25 2005-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
CA2385867C (en) * 1999-10-01 2009-09-01 Skw Trostberg Aktiengesellschaft Sustained release form comprising alpha-lipoic acid or derivatives thereof
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
EP1294353B1 (en) * 2000-06-06 2006-03-22 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
AU2003219880A1 (en) * 2002-02-22 2003-09-09 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
WO2006134609A2 (en) * 2005-06-16 2006-12-21 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
AP2008004567A0 (en) * 2006-01-31 2008-08-31 Parsroos Co Use of a combination of ethanolic Rosa SP., UrticaDiaca and tanacetum vulgare extracts, further com prising selenium and aure and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or tratment of HIV infections
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA014669B1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
CN107820422B (zh) * 2015-05-21 2022-02-08 摩纳哥奥夫塔尔米斯公司 包含硫辛酸和类粘液状聚合物的眼用组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A ( ) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
GR860712B (en) * 1985-03-16 1986-07-16 Wellcome Found Antiviral compounds
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
EP0318891B1 (de) * 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
ES2115589T3 (es) * 1989-11-09 1998-07-01 Asta Medica Ag Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
GR900100796A (en) 1992-04-17
IT1246328B (it) 1994-11-17
SE508601C2 (sv) 1998-10-19
EP0427246B1 (de) 1995-08-09
ES2076279T3 (es) 1995-11-01
SE9003564D0 (sv) 1990-11-08
FR2653997A1 (fr) 1991-05-10
NL9002438A (nl) 1991-06-03
IE904035A1 (en) 1991-05-22
GB2239797B (en) 1994-06-15
IT9048456A1 (it) 1992-05-08
AT500684B1 (de) 2006-10-15
DE4035456A1 (de) 1991-05-16
PT95827B (pt) 1997-11-28
DK173585B1 (da) 2001-04-02
GR1001503B (el) 1994-02-28
EP0427246A3 (en) 1992-06-03
DK0427246T3 (da) 1995-11-27
GR3017695T3 (en) 1996-01-31
CA2029599A1 (en) 1991-05-10
DK267790D0 (da) 1990-11-08
BE1003834A5 (fr) 1992-06-23
SE9003564L (sv) 1991-06-07
DK173752B1 (da) 2001-09-10
AT500684B8 (de) 2006-11-15
JPH03188021A (ja) 1991-08-16
GB9024252D0 (en) 1990-12-19
FR2653997B1 (fr) 1995-01-20
ATE126053T1 (de) 1995-08-15
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
EP0427246A2 (de) 1991-05-15
DE9017987U1 (de) 1993-12-09
AT500684A1 (de) 2006-02-15
DE59009497D1 (de) 1995-09-14
LU87834A1 (de) 1991-05-07
ES2029769A6 (es) 1992-09-01
IT9048456A0 (it) 1990-11-08
DK200001239A (da) 2000-08-22
US5334612A (en) 1994-08-02
GB2239797A (en) 1991-07-17
PT95827A (pt) 1991-09-13
DK267790A (da) 1991-05-10
BE1005018A3 (fr) 1993-03-23
IE67874B1 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
GR1000918B (el) Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
HUT51862A (en) Insecticides containing as active substance nitrocompositions and process for production of these compositions
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
ATE55247T1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DE68913762D1 (de) Diarylverbindungen als antiatherosklerotische Mittel.
SE8404065D0 (sv) Novel biologically active compounds
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
HUT50194A (en) Process for production of new derivatives of neplanocine and medical compositions containing them as active substance
DK552985A (da) Mercaptanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
HUT51284A (en) Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance
PT87737A (pt) Processo para a preparacao de composicoes farmaceuticas analgesicas contendo derivados de dioxopiperidina como substancia activa
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
HUT49456A (en) Fungicides containing as active substance derivatives of piridil-cycloprophan-carboxamidine
NO180269C (no) Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater
HUT45018A (en) Process for production of rapamicine-derivatives and medical compositions containing them as active substance
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
HUT44480A (en) Process for production of derivatives of /substituted amin-alkyl-amin or piperazinil/-naphtalin-dion and medical compounds containing them as active substance
PT85100A (pt) Processo para a preparacao de novos tetra-hidro-benzotiazois e de composicoes farmaceuticas que os contem
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
HUT47558A (en) Process for production of 12-halogene-forscoline derivatives and medical compositions containing them as active substance
ES535408A0 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.

Legal Events

Date Code Title Description
MA Right expired